1	Nos	nos	PP1CP000	-	-	0-3	320_QUEST_clinical_caseMIR	SENT1	-	-
2	remiten	remitir	VMIP3P0	C0439600	calificador	4-11	320_QUEST_clinical_caseMIR	SENT1	-	-
3	desde	desde	SPS00	-	-	12-17	320_QUEST_clinical_caseMIR	SENT1	-	-
4	oftalmología	oftalmología	NCFS000	C0029087	calificador	18-30	320_QUEST_clinical_caseMIR	SENT1	-	-
5	a	a	SPS00	-	-	31-32	320_QUEST_clinical_caseMIR	SENT1	-	-
6	un	un		C0205447_1	calificador_1	33-35	320_QUEST_clinical_caseMIR	SENT1	-	-
7	hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	36-42	320_QUEST_clinical_caseMIR	SENT1	-	-
8	de	de	SPS00	C0332285	atributo	43-45	320_QUEST_clinical_caseMIR	SENT1	-	-
9	31	31		-	-	46-48	320_QUEST_clinical_caseMIR	SENT1	-	-
10	años	año	NCMP000	C0439234	calificador	49-53	320_QUEST_clinical_caseMIR	SENT1	-	-
11	que	que	PR0CN000	-	-	54-57	320_QUEST_clinical_caseMIR	SENT1	-	-
12	consultó	consultar	VMIS3S0	-	-	58-66	320_QUEST_clinical_caseMIR	SENT1	-	-
13	por	por	SPS00	C0678226	atributo	67-70	320_QUEST_clinical_caseMIR	SENT1	-	-
14	pérdida	pérdida	NCFS000	-	-	71-78	320_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	de	de	SPS00	C0332285	atributo	79-81	320_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
16	visión	visión	NCFS000	C0042789	calificador	82-88	320_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
17	y	y	CC	C1706368	calificador	89-90	320_QUEST_clinical_caseMIR	SENT1	-	-
18	cefalea	cefalea	NCFS000	C0018681	hallazgo	91-98	320_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
19	progresiva	progresivo	AQ0FS0	C0205329	calificador	99-109	320_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
20	.	.	Fp	-	-	109-110	320_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	111-113	320_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	114-116	320_QUEST_clinical_caseMIR	SENT2	-	-
3	exploración	exploración	NCFS000	C1280903	procedimiento	117-128	320_QUEST_clinical_caseMIR	SENT2	-	-
4	fisica	fisica	AQ0FS00	-	-	129-135	320_QUEST_clinical_caseMIR	SENT2	-	-
5	se	se	P00CN000	-	-	136-138	320_QUEST_clinical_caseMIR	SENT2	-	-
6	constata	constatar	VMIP3S0	-	-	139-147	320_QUEST_clinical_caseMIR	SENT2	-	-
7	una	una		C0205447_1	calificador_1	148-151	320_QUEST_clinical_caseMIR	SENT2	-	-
8	hemianopsia	hemianopsia	NCFS000	C0018979	hallazgo	152-163	320_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
9	temporal	temporal	AQ0CS0	C0442043#C0205374	calificador	164-172	320_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
10	y	y	CC	C1706368	calificador	173-174	320_QUEST_clinical_caseMIR	SENT2	-	-
11	en	en	SPS00	C1720294#C0332285	calificador#atributo	175-177	320_QUEST_clinical_caseMIR	SENT2	-	-
12	la	el	DA0FS0	-	-	178-180	320_QUEST_clinical_caseMIR	SENT2	-	-
13	resonancia	resonancia	NCFS000	C0684213#C0231881	atributo#función	181-191	320_QUEST_clinical_caseMIR	SENT2	-	-
14	magnética	magnético	AQ0FS0	-	-	192-201	320_QUEST_clinical_caseMIR	SENT2	-	-
15	hipofisaria	hipofisario	AQ0FS0	-	-	202-213	320_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
16	una	una		C0205447_1	calificador_1	214-217	320_QUEST_clinical_caseMIR	SENT2	-	-
17	turnoración	turnoración	NCFS000	-	-	218-229	320_QUEST_clinical_caseMIR	SENT2	-	-
18	de	de	SPS00	C0332285	atributo	230-232	320_QUEST_clinical_caseMIR	SENT2	-	-
19	35	35		-	-	233-235	320_QUEST_clinical_caseMIR	SENT2	-	-
20	x	x	NCFS000	-	-	236-237	320_QUEST_clinical_caseMIR	SENT2	-	-
21	30	30		-	-	238-240	320_QUEST_clinical_caseMIR	SENT2	-	-
22	x	x	NCFS000	-	-	241-242	320_QUEST_clinical_caseMIR	SENT2	-	-
23	20	20	Z	-	-	243-245	320_QUEST_clinical_caseMIR	SENT2	-	-
24	mm	mm	NCMN000	-	-	246-248	320_QUEST_clinical_caseMIR	SENT2	-	-
25	que	que	PR0CN000	C0332260_1	calificador_1	249-252	320_QUEST_clinical_caseMIR	SENT2	-	-
26	comprime	comprimir	VMM02S0	C0332260_2	calificador_2	253-261	320_QUEST_clinical_caseMIR	SENT2	-	-
27	quiasma	quiasma	NCMS000	-	-	262-269	320_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
28	y	y	CC	C1706368	calificador	270-271	320_QUEST_clinical_caseMIR	SENT2	-	-
29	seno	seno	NCMS000	C1280187#C0007473_1	estructura_corporal_1	272-276	320_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
30	cavernoso	cavernoso	NC00SC0	C1280187#C0007473_2	estructura_corporal_2	277-286	320_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
31	.	.	Fp	-	-	286-287	320_QUEST_clinical_caseMIR	SENT2	-	-

1	Los	el	DA0MP0	-	-	288-291	320_QUEST_clinical_caseMIR	SENT3	-	-
2	resultados	resultado	NCMP000	C1704419#C1280500#C1280519#C1274040	concepto_para_navegación	292-302	320_QUEST_clinical_caseMIR	SENT3	-	-
3	del	del	SP+DA	-	-	303-306	320_QUEST_clinical_caseMIR	SENT3	-	-
4	estudio	estudio	NCMS000	C0557651	medio_ambiente	307-314	320_QUEST_clinical_caseMIR	SENT3	-	-
5	funcional	funcional	AQ0CS0	C0205245	calificador	315-324	320_QUEST_clinical_caseMIR	SENT3	-	-
6	son	ser	VSIP3P0	-	-	325-328	320_QUEST_clinical_caseMIR	SENT3	-	-
7	cortisol	cortisol	NC00SC0	C0020268	sustancia	329-337	320_QUEST_clinical_caseMIR	SENT3	-	-
8	14	14		-	-	338-340	320_QUEST_clinical_caseMIR	SENT3	-	-
9	microg	microgramo	NCMN000	C0439211	calificador	341-347	320_QUEST_clinical_caseMIR	SENT3	-	-
10	/	/	Fh	-	-	347-348	320_QUEST_clinical_caseMIR	SENT3	-	-
11	dL	decilitro	NCMN000	C0439241	calificador	348-350	320_QUEST_clinical_caseMIR	SENT3	-	-
12	,	,	Fc	-	-	350-351	320_QUEST_clinical_caseMIR	SENT3	-	-
13	TSH	thyroid-stimulating_hormone_(hormona__tiroestimulante)	NC00YL0	-	-	352-355	320_QUEST_clinical_caseMIR	SENT3	-	-
14	1,4	1,4		-	-	356-359	320_QUEST_clinical_caseMIR	SENT3	-	-
15	microU	microu	NCFS000	-	-	360-366	320_QUEST_clinical_caseMIR	SENT3	-	-
16	/	/	Fh	-	-	366-367	320_QUEST_clinical_caseMIR	SENT3	-	-
17	ml	mililitro	NCMN000	C0439242	calificador	367-369	320_QUEST_clinical_caseMIR	SENT3	-	-
18	,	,	Fc	-	-	369-370	320_QUEST_clinical_caseMIR	SENT3	-	-
19	T4L	T4L		-	-	371-374	320_QUEST_clinical_caseMIR	SENT3	-	-
20	1,2	1,2		-	-	375-378	320_QUEST_clinical_caseMIR	SENT3	-	-
21	ng	nasogástrico	NC00YL0	-	-	379-381	320_QUEST_clinical_caseMIR	SENT3	-	-
22	/	/	Fh	-	-	381-382	320_QUEST_clinical_caseMIR	SENT3	-	-
23	dL	decilitro	NCMN000	C0439241	calificador	382-384	320_QUEST_clinical_caseMIR	SENT3	-	-
24	,	,	Fc	-	-	384-385	320_QUEST_clinical_caseMIR	SENT3	-	-
25	prolactina	prolactina	NCFS000	C0033371	sustancia#producto	386-396	320_QUEST_clinical_caseMIR	SENT3	-	-
26	480	480		-	-	397-400	320_QUEST_clinical_caseMIR	SENT3	-	-
27	microg	microgramo	NCMN000	C0439211	calificador	401-407	320_QUEST_clinical_caseMIR	SENT3	-	-
28	/	/	Fh	-	-	407-408	320_QUEST_clinical_caseMIR	SENT3	-	-
29	L	l	NCFS000	-	-	408-409	320_QUEST_clinical_caseMIR	SENT3	-	-
30	(	(	Fpa	-	-	410-411	320_QUEST_clinical_caseMIR	SENT3	-	-
31	vn	valor_normal	NC00YL0	-	-	411-413	320_QUEST_clinical_caseMIR	SENT3	-	-
32	<	<	Fz	-	-	414-415	320_QUEST_clinical_caseMIR	SENT3	-	-
33	15	15		-	-	416-418	320_QUEST_clinical_caseMIR	SENT3	-	-
34	)	)	Fpt	-	-	418-419	320_QUEST_clinical_caseMIR	SENT3	-	-
35	,	,	Fc	-	-	419-420	320_QUEST_clinical_caseMIR	SENT3	-	-
36	testosterona	testosterona	NCFS000	C0039601	producto#sustancia	421-433	320_QUEST_clinical_caseMIR	SENT3	-	-
37	160	160		-	-	434-437	320_QUEST_clinical_caseMIR	SENT3	-	-
38	ng	nasogástrico	NC00YL0	-	-	438-440	320_QUEST_clinical_caseMIR	SENT3	-	-
39	/	/	Fh	-	-	440-441	320_QUEST_clinical_caseMIR	SENT3	-	-
40	dL	decilitro	NCMN000	C0439241	calificador	441-443	320_QUEST_clinical_caseMIR	SENT3	-	-
41	(	(	Fpa	-	-	444-445	320_QUEST_clinical_caseMIR	SENT3	-	-
42	vn	valor_normal	NC00YL0	-	-	445-447	320_QUEST_clinical_caseMIR	SENT3	-	-
43	300-1200	300-1200		-	-	448-456	320_QUEST_clinical_caseMIR	SENT3	-	-
44	)	)	Fpt	-	-	456-457	320_QUEST_clinical_caseMIR	SENT3	-	-
45	,	,	Fc	-	-	457-458	320_QUEST_clinical_caseMIR	SENT3	-	-
46	FSH	follicle-stimulating_hormone_(hormona_folículoestimulante)	NC00YL0	-	-	459-462	320_QUEST_clinical_caseMIR	SENT3	-	-
47	1,2	1,2		-	-	463-466	320_QUEST_clinical_caseMIR	SENT3	-	-
48	U	o	CC	-	-	467-468	320_QUEST_clinical_caseMIR	SENT3	-	-
49	/	/	Fh	-	-	468-469	320_QUEST_clinical_caseMIR	SENT3	-	-
50	I.	i.	NCFS000	-	-	469-471	320_QUEST_clinical_caseMIR	SENT3	-	-
51	,	,	Fc	-	-	471-472	320_QUEST_clinical_caseMIR	SENT3	-	-
52	(	(	Fpa	-	-	473-474	320_QUEST_clinical_caseMIR	SENT3	-	-
53	vn	valor_normal	NC00YL0	-	-	474-476	320_QUEST_clinical_caseMIR	SENT3	-	-
54	5-15	5-15		-	-	477-481	320_QUEST_clinical_caseMIR	SENT3	-	-
55	)	)	Fpt	-	-	481-482	320_QUEST_clinical_caseMIR	SENT3	-	-
56	y	y	CC	C1706368	calificador	483-484	320_QUEST_clinical_caseMIR	SENT3	-	-
57	LH	luteinizing_hormone_(hormona_luteinizante)	NC00YL0	-	-	485-487	320_QUEST_clinical_caseMIR	SENT3	-	-
58	2	2		-	-	488-489	320_QUEST_clinical_caseMIR	SENT3	-	-
59	U	o	CC	-	-	490-491	320_QUEST_clinical_caseMIR	SENT3	-	-
60	/	/	Fh	-	-	491-492	320_QUEST_clinical_caseMIR	SENT3	-	-
61	L	l	NCFS000	-	-	492-493	320_QUEST_clinical_caseMIR	SENT3	-	-
62	(	(	Fpa	-	-	494-495	320_QUEST_clinical_caseMIR	SENT3	-	-
63	vn	valor_normal	NC00YL0	-	-	495-497	320_QUEST_clinical_caseMIR	SENT3	-	-
64	3-15	3-15		-	-	498-502	320_QUEST_clinical_caseMIR	SENT3	-	-
65	)	)	Fpt	-	-	502-503	320_QUEST_clinical_caseMIR	SENT3	-	-
66	.	.	Fp	-	-	503-504	320_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	505-506	320_QUEST_clinical_caseMIR	SENT4	-	-
2	Cuál	cuál	PT0CS000	-	-	506-510	320_QUEST_clinical_caseMIR	SENT4	-	-
3	es	ser	VSIP3S0	-	-	511-513	320_QUEST_clinical_caseMIR	SENT4	-	-
4	el	el	DA0MS0	-	-	514-516	320_QUEST_clinical_caseMIR	SENT4	-	-
5	abordaje	abordaje	NCMS000	C1292724#C0449445	atributo	517-525	320_QUEST_clinical_caseMIR	SENT4	-	-
6	terapéutico	terapéutico	AQ0MS0	-	-	526-537	320_QUEST_clinical_caseMIR	SENT4	-	-
7	inicial	inicial	AQ0CS0	C0205265	calificador	538-545	320_QUEST_clinical_caseMIR	SENT4	-	-
8	?	?	Fit	-	-	545-546	320_QUEST_clinical_caseMIR	SENT4	-	-
9	:	:	Fd	-	-	546-547	320_QUEST_clinical_caseMIR	SENT4	-	-
10	.	.	Fp	-	-	547-548	320_QUEST_clinical_caseMIR	SENT4	-	-

